Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to CR7618ApriorityCriticalpatent/CR7618A/en
Publication of CR7618ApublicationCriticalpatent/CR7618A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Se refiere a inhibidores de la proteina de transferencia de esteres de colesterilo (PTEC), a composiciones farmaceuticas que contienen dichos inhibidores y al uso de dichos inhibidores para tratar ciertas enfermedades/estados, opcionalmente combinados con ciertos agentes terapeuticos, por ejemplo agentes hipertensivosIt refers to cholesteryl ester transfer protein (PTEC) inhibitors, pharmaceutical compositions containing said inhibitors and the use of said inhibitors to treat certain diseases / conditions, optionally combined with certain therapeutic agents, for example hypertensive agents.
CR7618A2004-12-102004-12-10
TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS
CR7618A
(en)
A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use.